D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
First Trust Technology AlphaDEX Fund
FXL
$2.49B
| $443K | ﹤0.01% |
2,982
| – | – |
|
3552
Enel Chile
ENIC
$6.05B
| $442K | ﹤0.01% |
153,528
+20,110
| +15% | +$55.9K |
|
3553
State Street SPDR S&P Capital Markets ETF
KCE
$456M
| $442K | ﹤0.01% |
+3,211
| New | +$444K |
|
3554
i3 Verticals
IIIV
$404M
| $441K | ﹤0.01% |
19,140
-16,211
| -46% | -$380K |
|
|
SPR
3555
DELISTED
Spirit AeroSystems
SPR
| $440K | ﹤0.01% |
+12,920
| New | +$417K |
|
3556
Leonardo DRS
DRS
$12.9B
| $440K | ﹤0.01% |
+13,618
| New | +$442K |
|
|
UHGWW
3557
DELISTED
United Homes Group Warrant
UHGWW
| $440K | ﹤0.01% |
439,789
| – | – |
|
3558
Columbus McKinnon
CMCO
$472M
| $439K | ﹤0.01% |
11,801
-69,975
| -86% | -$2.54M |
|
|
SMLR
3559
DELISTED
Semler Scientific
SMLR
| $439K | ﹤0.01% |
+8,132
| New | +$374K |
|
3560
PUT
Universal Display
OLED
$3.81B
| $439K | ﹤0.01% |
3,000
+1,900
| +173% | +$338K |
|
3561
Korea Electric Power
KEP
$15.7B
| $438K | ﹤0.01% |
63,594
+19,848
| +45% | +$155K |
|
3562
Navigator Holdings
NVGS
$1.34B
| $437K | ﹤0.01% |
28,458
-78,245
| -73% | -$1.23M |
|
3563
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.83B
| $436K | ﹤0.01% |
10,378
-16,039
| -61% | -$693K |
|
|
UHT
3564
Universal Health Realty Income Trust
UHT
$614M
| $436K | ﹤0.01% |
11,715
+4,699
| +67% | +$191K |
|
3565
SmartRent
SMRT
$186M
| $434K | ﹤0.01% |
+248,194
| New | +$416K |
|
|
ITOS
3566
DELISTED
iTeos Therapeutics
ITOS
| $434K | ﹤0.01% |
56,534
-69,227
| -55% | -$595K |
|
3567
Enovis
ENOV
$1.63B
| $432K | ﹤0.01% |
9,849
-87,556
| -90% | -$3.85M |
|
3568
Flowserve
FLS
$9.29B
| $432K | ﹤0.01% |
7,503
-18,904
| -72% | -$1.08M |
|
3569
ROBO Global Robotics & Automation Index ETF
ROBO
$1.94B
| $431K | ﹤0.01% |
7,658
-701
| -8% | -$39.9K |
|
3570
Evercore
EVR
$13.2B
| $431K | ﹤0.01% |
1,554
+54
| +4% | +$15.3K |
|
3571
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.19B
| $429K | ﹤0.01% |
+12,274
| New | +$487K |
|
3572
Colony Bankcorp
CBAN
$460M
| $428K | ﹤0.01% |
26,527
-8,702
| -25% | -$142K |
|
3573
PLAYSTUDIOS Inc
MYPS
$78.4M
| $428K | ﹤0.01% |
230,008
+12,415
| +6% | +$21.3K |
|
3574
ALX Oncology
ALXO
$272M
| $427K | ﹤0.01% |
255,878
-34,518
| -12% | -$53.1K |
|
3575
Sarepta Therapeutics
SRPT
$1.68B
| $426K | ﹤0.01% |
3,500
-18,239
| -84% | -$2.24M |
|
Similar funds
D.E. Shaw & Co's Q4 2024 Portfolio in Review
As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.